25180 Federal Register / Vol. 77, No. 82 / Friday, April 27, 2012 / Notices 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: 

pso@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act, Public Law 

109–41, 42 U.S.C. 299b–21—b–26, 

provides for the formation of PSOs, 

which collect, aggregate, and analyze 

confidential information regarding the 

quality and safety of health care 

delivery. The Patient Safety Rule, 42 

CFR part 3, authorizes AHRQ, on behalf 

of the Secretary of HHS, to list as a PSO 

an entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found to no longer 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule. 

Section 3.108(d) of the Patient Safety 

Rule requires AHRQ to provide public 

notice when it removes an organization 

from the list of federally approved PS0s, 

including when a PSO chooses to 

voluntarily relinquish its status as a 

PSO for any reason. Accordingly, 

Surgical Safety Institute, PSO number 

P0056, was delisted effective at 12:00 

Midnight ET (2400) on February 21, 

2012. 

More information on PSOs can be 

obtained through AHRQ’s PSO Web site 

at http://www.pso.AHRQ.gov/ 

index.html. 

Dated: April 19, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–10012 Filed 4–26–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Immunization 

Practices: Notice of Charter Renewal 

This gives notice under the Federal 

Advisory Committee Act (Pub. L. 92– 

463) of October 6, 1972, that the 

Advisory Committee on Immunization 

Practices, Centers for Disease Control 

and Prevention, Department of Health 

and Human Services, has been renewed 

for a 2-year period through April 1, 

2014. 

For Further Information Contact: 

Larry Pickering, M.D., Designated 

Federal Officer, Advisory Committee on 

Immunization Practices, Centers for 

Disease Control and Prevention, 

Department of Health and Human 

Services, 1600 Clifton Road NE., 

Mailstop A27, Atlanta, Georgia 30333, 

telephone (404) 639–8562 or fax (404) 

639–8626. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 23, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–10214 Filed 4–26–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Conducting Research on 

Moderate Acute Malnutrition in 

Humanitarian Emergencies, Funding 

Opportunity Announcement (FOA) 

GH12–006, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12:30 p.m.–4:30 p.m., May 

22, 2012 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Conducting Research on 

Moderate Acute Malnutrition in 

Humanitarian Emergencies, FOA GH12–006, 

initial review.’’ 

Contact Person for More Information: 

Sheree Williams, Scientific Review Officer, 

Office of the Associate Director for Science, 

Office of Science Quality, CDC, 1600 Clifton 

Road NE., Mailstop D–72, Atlanta, Georgia 

30033, Telephone (404) 639–7742. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 23, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–10260 Filed 4–26–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Evaluation of Dengue 

Epidemiology, Outcomes, and 

Prevention in Sentinel Surveillance and 

Research Sites in Puerto Rico, Funding 

Opportunity Announcement (FOA), 

CK12–001, initial review. 

Correction: The notice was published 

in the Federal Register on January 26, 

2012, Volume 77, Number 17, Page 

4048. The meeting has been rescheduled 

to the following: 

Time and Date: 

1 p.m.–5 p.m., May 4, 2012 (Closed). 

Contact Person for More Information: 

Gregory Anderson, M.P.H., M.S., 

Scientific Review Officer, CDC, 1600 

Clifton Road NE., Mailstop E60, Atlanta, 

Georgia 30333, Telephone: (404) 718– 

8833. The Director, Management 

Analysis and Services Office, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 23, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–10213 Filed 4–26–12; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on DSK4VPTVN1PROD with NOTICES